BCL2 and acute respiratory distress syndrome: The Bcl‐2 family inhibitor ABT‐737 has been shown to promote neutrophil apoptosis, reducing accumulation and associated tissue damage in preclinical models of ALI and ischemia–reperfusion injury.429